161 related articles for article (PubMed ID: 38474372)
1. Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression.
Dalle Carbonare L; Minoia A; Vareschi A; Piritore FC; Zouari S; Gandini A; Meneghel M; Elia R; Lorenzi P; Antoniazzi F; Pessoa J; Zipeto D; Romanelli MG; Guardavaccaro D; Valenti MT
Cells; 2024 Feb; 13(5):. PubMed ID: 38474372
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer.
Guo ZJ; Yang L; Qian F; Wang YX; Yu X; Ji CD; Cui W; Xiang DF; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Oncotarget; 2016 Apr; 7(15):20999-1012. PubMed ID: 27007162
[TBL] [Abstract][Full Text] [Related]
3. A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells.
Deiana M; Dalle Carbonare L; Serena M; Cheri S; Mutascio S; Gandini A; Innamorati G; Lorenzi P; Cumerlato M; Bertacco J; Antoniazzi F; Romanelli MG; Mottes M; Zipeto D; Valenti MT
Cells; 2020 Mar; 9(3):. PubMed ID: 32204402
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis.
Mannavola F; Tucci M; Felici C; Passarelli A; D'Oronzo S; Silvestris F
J Transl Med; 2019 Jul; 17(1):230. PubMed ID: 31324252
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells.
Jin Z; Xiang R; Dai J; Wang Y; Xu Z
Mol Carcinog; 2023 May; 62(5):676-684. PubMed ID: 36789975
[TBL] [Abstract][Full Text] [Related]
7. Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells.
Tandon M; Chen Z; Pratap J
Breast Cancer Res; 2014 Jan; 16(1):R16. PubMed ID: 24479521
[TBL] [Abstract][Full Text] [Related]
8. SDF-1α Promotes Chondrocyte Autophagy through CXCR4/mTOR Signaling Axis.
Li J; Chen H; Cai L; Guo D; Zhang D; Zhou X; Xie J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675225
[TBL] [Abstract][Full Text] [Related]
9. mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression.
Dai Q; Xu Z; Ma X; Niu N; Zhou S; Xie F; Jiang L; Wang J; Zou W
Cell Death Differ; 2017 Nov; 24(11):1886-1899. PubMed ID: 28686577
[TBL] [Abstract][Full Text] [Related]
10. RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.
Boregowda RK; Olabisi OO; Abushahba W; Jeong BS; Haenssen KK; Chen W; Chekmareva M; Lasfar A; Foran DJ; Goydos JS; Cohen-Solal KA
Cancer Lett; 2014 Jun; 348(1-2):61-70. PubMed ID: 24657655
[TBL] [Abstract][Full Text] [Related]
11. Effects of runt-related transcription factor 2 (
Ren C; Xu Y; Liu H; Wang Z; Ma T; Li Z; Sun L; Huang Q; Zhang K; Zhang C; Cui Y; Wang Q; Lu Y
Bioengineered; 2022 Mar; 13(3):5262-5276. PubMed ID: 35170378
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition.
Liao YX; Lv JY; Zhou ZF; Xu TY; Yang D; Gao QM; Fan L; Li GD; Yu HY; Liu KY
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34080667
[TBL] [Abstract][Full Text] [Related]
13. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
14. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
[TBL] [Abstract][Full Text] [Related]
15. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells.
Pande S; Browne G; Padmanabhan S; Zaidi SK; Lian JB; van Wijnen AJ; Stein JL; Stein GS
J Cell Physiol; 2013 Aug; 228(8):1784-92. PubMed ID: 23389849
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
Weekes CD; Song D; Arcaroli J; Wilson LA; Rubio-Viqueira B; Cusatis G; Garrett-Mayer E; Messersmith WA; Winn RA; Hidalgo M
Neoplasia; 2012 Aug; 14(8):690-701. PubMed ID: 22952422
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells.
Marino ML; Fais S; Djavaheri-Mergny M; Villa A; Meschini S; Lozupone F; Venturi G; Della Mina P; Pattingre S; Rivoltini L; Codogno P; De Milito A
Cell Death Dis; 2010 Oct; 1(10):e87. PubMed ID: 21368860
[TBL] [Abstract][Full Text] [Related]
19. Panduratin A induces protective autophagy in melanoma via the AMPK and mTOR pathway.
Lai SL; Mustafa MR; Wong PF
Phytomedicine; 2018 Mar; 42():144-151. PubMed ID: 29655680
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma.
Boregowda RK; Medina DJ; Markert E; Bryan MA; Chen W; Chen S; Rabkin A; Vido MJ; Gunderson SI; Chekmareva M; Foran DJ; Lasfar A; Goydos JS; Cohen-Solal KA
Oncotarget; 2016 May; 7(20):29689-707. PubMed ID: 27102439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
